OliX Pharmaceuticals, Inc.
Developing RNAi therapeutics for dermatology, ophthalmology, and metabolic diseases via an asiRNA platform.
226950 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 고등동 608-3 -, 성남시
- Website:
- https://olixpharma.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
OliX Pharmaceuticals, Inc. is a clinical-stage biotechnology company that specializes in the development of novel therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric small interfering RNA (asiRNA) platform to discover and advance next-generation nucleic acid-based treatments. Its development pipeline is focused on addressing diseases with high unmet medical needs, particularly in dermatology, ophthalmology, and metabolic disorders. Key programs in its pipeline target conditions such as hypertrophic scars, androgenetic alopecia (male-pattern baldness), age-related macular degeneration (AMD), and metabolic dysfunction-associated steatohepatitis (MASH). OliX aims to develop locally administrable therapies to improve safety and efficacy, positioning itself as an innovator in oligonucleotide therapeutics.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for OliX Pharmaceuticals, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | |
| 2025-09-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | |
| 2025-09-09 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 146.9 KB | |
| 2025-08-28 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.7 KB | |
| 2025-08-26 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 14.3 KB | |
| 2025-08-19 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | |
| 2025-08-19 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | |
| 2025-08-19 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 164.1 KB | |
| 2025-08-19 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 125.8 KB | |
| 2025-08-19 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | |
| 2025-08-14 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 23.7 KB | |
| 2025-08-14 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 22.7 KB | |
| 2025-08-14 00:00 |
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
|
Korean | 22.3 KB | |
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.7 MB | |
| 2025-08-14 00:00 |
Legal Proceedings Report
파생상품거래손실발생
|
Korean | 6.2 KB |
Automate Your Workflow. Get a real-time feed of all OliX Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OliX Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
